Xu, F., Cheng, Y., Wang, Y., Xin, T., Jin, B., Fang, J., Liang, L., Li, X., Tang, C., Liu, Y., Cui, H., Yan, D., Li, L., Zhang, Y., Zhang, L., Zhou, Y., Mu, X. L. (2025). Hyperlipidemia as adverse event of lorlatinib, a multicenter cohort study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e24040